The Cardiac Microvasculature in Hypertension, Cardiac Hypertrophy and Diastolic Heart Failure
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Recent studies revealed an exceedingly high mortality with diastolic heart failure that was previously regarded as relatively benign compared to systolic heart failure. Prominent risk factors for diastolic heart failure are increasing age, hypertension and diabetes. These risk factors are associated with coronary microvascular rarefaction and resultant decreased coronary flow reserve, thereby rendering the myocardium vulnerable to ischemia. We discuss the importance of angiogenic gene programming in preserving the coronary microvasculature, preserving cardiac function and altering disease course. Further, we discuss the possible utility of therapies that activate hypoxia inducible factor-1 in preventing rarefaction of the coronary microvasculature and maintaining cardiac diastolic function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Adams, V., Lenk, K., Linke, A., Lenz, D., Erbs, S., Sandri, M., Tarnok, A., Gielen, S., Emmrich, F., Schuler, G., et al. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000124104.23702.a0 · Cited by 367
Rakusan, K., Flanagan, M. F., Geva, T., Southern, J., & Van Praagh, R. (1992) · Circulation · doi:10.1161/01.cir.86.1.38 · Cited by 327
Cited by
Mohammed, S. F., Hussain, S., Mirzoyev, S. A., Edwards, W. D., Maleszewski, J. J., & Redfield, M. M. (2015) · Circulation · doi:10.1161/circulationaha.114.009625 · Cited by 874
“The resultant reduction in coronary microvascular density (MVD) may impair oxygen delivery with stress, limiting LV systolic and diastolic reserve function.(19,20) However, studies in human HFpEF myocardium are limited, and MVD, in particular, has not been assessed in HFpEF.”
BackgroundHypertension-induced cognitive impairment: From pathophysiology to public health
Ungvari, Z., Toth, P., Tarantini, S., Prodan, C. I., Sorond, F., Merkely, B., & Csiszar, A. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00430-6 · Cited by 544
ter Maaten, J. M., Damman, K., Verhaar, M. C., Paulus, W. J., Duncker, D. J., Cheng, C., van Heerebeek, L., Hillege, H. L., Lam, C. S. P., Navis, G., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.497 · Cited by 320
Elimination of Vitamin D Receptor in Vascular Endothelial Cells Alters Vascular Function
Ni, W., Watts, S. W., Ng, M., Chen, S., Glenn, D. J., & Gardner, D. G. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03971 · Cited by 168
Soudani, N., Ghantous, C. M., Farhat, Z., Shebaby, W. N., Zibara, K., & Zeidan, A. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00433 · Cited by 21
Metadata
- Authors
- Hoenig, M., Bianchi, C., Rosenzweig, A., & Sellke, F.
- Venue
- Current Vascular Pharmacology
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2008-10-01
- Volume
- 6
- Issue
- 4
- Pages
- 292-300
- ISSN
- 1570-1611 (ISSN-L)
- OpenAlex
- W2116094708
- Cited by
- 76
- References
- 4
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Cardiac Microvasculature in Hypertension, Cardiac Hypertrophy and Diastolic Heart Failure. https://app.cochat.ai/papers/10.2174/157016108785909779
- The paper
- Hoenig, M., Bianchi, C., Rosenzweig, A., & Sellke, F. (2008). The Cardiac Microvasculature in Hypertension, Cardiac Hypertrophy and Diastolic Heart Failure. Current Vascular Pharmacology. https://doi.org/10.2174/157016108785909779
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.